CONMED Corp — Director's Dealing 2025

Nov 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2025-10-31

Reporting Person: Garner Todd W (Executive Vice President & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-31	Common Stock	M	7500	—	Acquired	7500	Direct
2025-10-31	Common Stock	F	2164	$44.00	Disposed	5336	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-31	RSUs (Restricted Stock Units)	$	M	7500	Disposed		Common Stock (7500)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company").

F2: The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan vesting over two years with 33% vesting after year 1 and 67% vesting after year 2.